Feasibility of preoperative and postoperative chemoradiotherapy in gastric adenocarcinoma. Two phase II studies done in parallel. Fédération Francophone de Cancérologie Digestive 0308

European Journal of Cancer

Volumn 50, Issue 6, 2014, Pages 1076-1083

  Michel, Pierre ^a   Breysacher, Gilles ^b   Mornex, Françoise ^c   Seitz, Jean François ^d   Pere Verge, Denis ^e   Martel Lafay, Isabelle ^f   Faroux, Roger ^g   Chapet, Sophie ^h   Sobhani, Iradj ⁱ   Pezet, Denis ^j   Aparicio, Thomas ⁱ   Nguyen, Suzanne ^k   Dousset, Bertrand ^l   Jouve, Jean Louis ^m   Maillard, Emilie ⁿ  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b Pasteur Hospital   (France)

^c CENTRE HOSPITALIER LYON SUD   (France)

^d TIMONE HOSPITAL   (France)

^e UNIVERSITÉ DE LYON   (France)

^f CENTRE LÉON BÉRARD   (France)

^g Centre Hospitalier la Roche sur Yon   (France)

^h UNIVERSITY HOSPITAL OF TOURS   (France)

ⁱ ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^j Centre Hospitalo Universitaire   (France)

^k CENTRE HOSPITALIER   (France)

^l Institut Cochin   (France)

^m DIJON UNIVERSITY HOSPITAL   (France)

ⁿ NONE   (France)

more..

Author keywords

Adjuvant treatment; Chemo radiotherapy; Gastric cancer

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; SERUM ALBUMIN;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONTINUOUS INFUSION; DIET RESTRICTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; QUALITY OF LIFE; STOMACH ADENOCARCINOMA;

ADJUVANT TREATMENT; CHEMO RADIOTHERAPY; GASTRIC CANCER;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; CHEMORADIOTHERAPY; DOSE FRACTIONATION; FEASIBILITY STUDIES; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; STOMACH; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84897046014     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.12.009     Document Type: Article

References (19)

1. G.A. Brooks, P.C. Enzinger, and C.S. Fuchs Adjuvant therapy for gastric cancer: revisiting the past to clarify the future J Clin Oncol 30 2012 2297 2299
2. J.S. MacDonald, S.R. Smalley, J. Benedetti, S.A. Hundahl, N.C. Estes, and G.N. Stemmermann et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction N Engl J Med 345 2001 725 730
3. D. Cunningham, W.H. Allum, S.P. Stenning, J.N. Thompson, C.J.H. Van de Velde, and M. Nicolson et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 2006 11 20
4. M. Ychou, V. Boige, J.P. Pignon, T. Conroy, O. Bouché, and G. Lebreton et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial J Clin Oncol 29 2011 1715 1721
5. S.R. Smalley, J.K. Benedetti, D.G. Haller, S.A. Hundhal, N.C. Estes, and J.A. Ajani et al. Updated analysis of SWOG-directed intergroup study 0116; a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection J Clin Oncol 30 2012 2327 2333
6. J. Lee, D.H. Lim, S. Kim, S.H. Park, J.O. Park, and Y.S. Park et al. Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial J Clin Oncol 30 2012 268 273
7. N. Ohri, M.K. Garg, S. Aparo, A. Kaubisch, W. Tome, and T.J. Kennedy et al. Who benefits from adjuvant radiation therapy for gastric cancer? A meta-analysis Int J Radiation Oncol Biol Phys 86 2013 330 335
8. J.A. Ajani, P.F. Mansfield, N. Janjan, J. Morris, P.W. Pisters, and P.M. Lynch et al. Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma J Clin Oncol 22 2004 2774 2780
9. A.D. Roth, A.S. Allal, and M.A. Brundler et al. Neoadjuvant radiochemotherapy for locally advanced gastric cancer: a phase I-II study Ann Oncol 14 2003 110 115
10. J.A. Ajani, K. Winter, G.S. Okawara, J.H. Donohue, P.W.T. Pisters, and C.H. Crane et al. Phase II trial of preoperative chemoradiotherapy in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response J Clin Oncol 24 2006 3953 3958
11. V. Valenti, J.L. Hernandez-Lizoain, M.C. Beorlegui, J.A. Diaz-Gozalez, F.M. Regueira, and J.J. Rodriguez et al. Morbidity, mortality, and pathological response in patients with gastric cancer preoperatively treated with chemotherapy or chemoradiotherapy J Surg Oncol 104 2011 124 129
12. J. Wydmański, R. Suwinski, S. Poltorak, B. Maka, L. Miszczyk, and E. Wolny et al. The tolerance and efficacy of preoperative chemoradiotherapy followed by gastrectomy in operable gastric cancer, a phase II study Radiother Oncol 82 2007 132 136
13. T. Inoue, S. Yachida, H. Usuki, T. Kimura, M. Hagiike, and K. Okano et al. Pilot feasibility study of neoadjuvant chemoradiotherapy with S-1 in patients with locally advanced gastric cancer featuring adjacent tissue invasion or JGCA bulky N2 lymph node metastases Ann Surg Oncol 19 2012 2937 2945
14. M. Stahl, M.K. Walz, M. Stuschke, N. Lehmann, H.J. Meyer, and J. Riera-Knorrenschild et al. Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction J Clin Oncol 27 2009 851 856
15. T.R. Fleming One sample multiple testing procedure for phase II clinical trials Biometrics 38 1982 143 151
16. O. Bouché, J.L. Raoul, F. Bonnetain, M. Giovannini, P.L. Etienne, and G. Lledo et al. Randomized multicenter phase II trial of a biweekly regimen of fluorouracil and leucovorin (LV5FU2), LV5FU2 plus cisplatin, or lV5FU2 plus irinotecan in patients with previously untreated metastatic gastric cancer: a Fédération Francophone de Cancérologie Digestive Group Study - FFCD 9803 J Clin Oncol 22 2004 4319 4328
17. R. Guimbaud, C. Louvet, F. Bonnetain, F. Viret, E. Samalin, and J. Gomet et al. Final results of the intergroup FFCD-GERCOR-FNCLCC 03-07 phase III study comparing two sequences of chemotherapy in advanced gastric cancers Ann Oncol 21 Suppl. 8 2010 viii250 viii263 [abs 8010]
18. E. Newman, S.G. Marcus, M. Potmesil, S. Sewak, H. Yee, and J. Sorich et al. Neoadjuvant chemotherapy with CPT-11 and cisplatin downstages locally advanced gastric cancer J Gastrointest Surg 6 2002 212 223
19. F. Di Fiore, S. Lecleire, D. Pop, O. Rigal, H. Hamidou, and B. Paillot et al. Baseline nutritional status predictive of response to treatment and survival patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer Am J Gastroenterol 102 2007 2557 2563